Drugs / Qinggongshoutao Bolus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02982603 | May 2015 → Dec 2017 | cognitive impairment with or without cerebellar ataxia, drug allergy | Dongzhimen Hospital, Beijing | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qinggongshoutao Bolus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02982603 ↗ |